Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide
about
TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetesActivation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.Immunologic endocrine disorders.Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages.Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice.RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in miceNoncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination.Viral trigger for type 1 diabetes: pros and consTLR2 signaling improves immunoregulation to prevent type 1 diabetesdsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9-23 alpha chainsProteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97.Potential mechanisms of interferon-alpha induced autoimmunity.Type 1 diabetes: recent developmentsEvidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness.Interferons as pathogenic effectors in autoimmunity.The stages of type 1A diabetes: 2005.Regulation of B lymphocyte responses to Toll-like receptor ligand binding during diabetes prevention in non-obese diabetic (NOD) miceA role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice.Insulin as an autoantigen in NOD/human diabetesMicrobiota and autoimmunityInnate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cellsInduction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes.Homing of GAD65 specific autoimmunity and development of insulitis requires expression of both DQ8 and human GAD65 in transgenic mice.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.Toll-Like Receptor Activation in Immunity vs. Tolerance in Autoimmune Diabetes.Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes.Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus.Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.Functional characterization of the Thr946Ala SNP at the type 1 diabetes IFIH1 locus.Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice.Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction.Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses.Polymorphisms of the Toll-Like Receptor-3 Gene in Autoimmune Adrenal Failure and Type 1 Diabetes in Polish Patients.Characterization of vector-based delivery of neurogenin-3 in murine diabetes.Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset.Insulin: a critical autoantigen and potential therapeutic agent in Type 1 diabetes.Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells.Effects of polyinosinic-polycytidylic acid and adoptive transfer of immune cells in the Lew.1AR1-iddm rat and in its coisogenic LEW.1AR1 background strain.
P2860
Q27025559-DF14B8EA-8502-4555-A121-8E2EBB05F532Q30424360-81C5AA78-C3BD-41C0-B168-328B04302790Q33714100-57E135A9-1D3C-447F-8E8E-981E685EB67DQ34144580-F146C726-51FC-42F2-8D3A-A27F39AC7057Q34150003-BAE121C6-B670-4D8C-B1DD-ACF5A4334A98Q34755163-C1CF3C71-E055-4544-9298-16DED1AA4FC4Q34785725-C7796485-3A31-4135-B26E-D6CCF11C8D66Q34868678-08EE702D-1CD9-4F4E-BE6E-4D6A89F0B5E2Q34999656-C7A6CF48-8577-418E-9931-BF294D28728AQ35205757-FF1F3E33-1032-42EA-8C62-D9C3888E95F4Q35248766-642474DE-D63E-4517-9DF0-02F837714850Q35672979-304F551B-5B4B-4833-B5BC-F146D310EE2EQ35675531-7508A2C0-17ED-424F-910A-DCE0600937E9Q35714822-D4AA89BA-8E30-440A-9D7F-74E7A27BCAF9Q35918236-7A6C5A00-2F1F-44D2-BCAE-4BD9F45FBC33Q36068765-5D9674D9-A89F-43FA-B381-7CAD6EE5BB87Q36079852-70E14F4B-CC1B-4DD1-99F5-A2F53A83819CQ36079915-23AC31B6-71C9-44A5-803D-B2F6C690A6FBQ36137667-20B4ABC9-FE46-424C-9943-E7468D8B6643Q36403371-23DBC980-D885-40F3-BA80-B03DB198F288Q36499414-6902237B-9272-4299-9C1E-458B51415971Q36626681-B1DFAA7D-6BA0-4738-BD81-2004B42E72B8Q36932371-7ED435F7-C5E9-4119-AC5B-7B7F6AC188EBQ37185883-EB0CF04C-46A7-4978-B33D-4FC0613EAE8AQ37248995-52584FE0-7276-4DB0-9D8B-D9BE1D4DCB3AQ37736589-52AB4A36-7393-4215-A2C9-5C5A4A991751Q38203260-95166A2F-3031-4D51-8542-BDCE39E6E65EQ38385670-89DD682E-A3C0-457B-A6C3-5BBBB3EEDFD0Q38450410-E707C88B-4424-412C-8373-4D90EEBCA7EBQ38840238-E53B8C29-ADB3-4A2A-B891-26C10E234FB9Q39080994-32E5B316-D3C5-499A-BF4E-B6880DB441ABQ39174728-FAAB3787-EEB0-4C4A-A80B-4DB5ADE52614Q39741038-4C97C026-D02E-4BAD-BBB8-11F745198D72Q40953830-63787553-E4F1-4EBB-B9E0-BD35B175BE0DQ41026950-3ED7D828-7789-499C-8F4D-988964F19807Q41893785-29B92720-F825-4A26-8240-6608C3914AAAQ41919675-9EC149F0-F954-4F04-8146-62F47268EA65Q43061716-73583147-327F-42C0-ADA5-4591571FD526Q45983510-446ED50F-D31C-47EC-98F3-9A5AD85299F4Q46737171-6755BA67-F5F0-4A1E-A723-1BD1D1D67211
P2860
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Induction and acceleration of ...... d) and an insulin self-peptide
@ast
Induction and acceleration of ...... d) and an insulin self-peptide
@en
Induction and acceleration of insulitis/diabetes in mice with a viral mimic
@nl
type
label
Induction and acceleration of ...... d) and an insulin self-peptide
@ast
Induction and acceleration of ...... d) and an insulin self-peptide
@en
Induction and acceleration of insulitis/diabetes in mice with a viral mimic
@nl
prefLabel
Induction and acceleration of ...... d) and an insulin self-peptide
@ast
Induction and acceleration of ...... d) and an insulin self-peptide
@en
Induction and acceleration of insulitis/diabetes in mice with a viral mimic
@nl
P2093
P2860
P356
P1476
Induction and acceleration of ...... d) and an insulin self-peptide
@en
P2093
Dongmei Miao
George S Eisenbarth
Hiroaki Moriyama
Norio Abiru
Roberto Gianani
P2860
P304
P356
10.1073/PNAS.082120099
P407
P577
2002-04-09T00:00:00Z